- Home
- TALO vs AMPH Comparison
TALO vs AMPH Comparison
Compare TALO & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALO
- AMPH
- Stock Information
- Founded
- TALO 2011
- AMPH 1996
- Country
- TALO United States
- AMPH United States
- Employees
- TALO N/A
- AMPH N/A
- Industry
- TALO Oil & Gas Production
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- TALO Energy
- AMPH Health Care
- Exchange
- TALO Nasdaq
- AMPH Nasdaq
- Market Cap
- TALO 2.0B
- AMPH 2.5B
- IPO Year
- TALO N/A
- AMPH 2014
- Fundamental
- Price
- TALO $10.18
- AMPH $51.45
- Analyst Decision
- TALO Strong Buy
- AMPH Buy
- Analyst Count
- TALO 10
- AMPH 4
- Target Price
- TALO $18.25
- AMPH $63.00
- AVG Volume (30 Days)
- TALO 1.8M
- AMPH 268.7K
- Earning Date
- TALO 11-04-2024
- AMPH 11-06-2024
- Dividend Yield
- TALO N/A
- AMPH N/A
- EPS Growth
- TALO N/A
- AMPH 62.07
- EPS
- TALO N/A
- AMPH 3.15
- Revenue
- TALO $1,744,933,000.00
- AMPH $712,891,000.00
- Revenue This Year
- TALO $40.71
- AMPH $18.04
- Revenue Next Year
- TALO $0.54
- AMPH $4.41
- P/E Ratio
- TALO N/A
- AMPH $16.26
- Revenue Growth
- TALO 24.09
- AMPH 31.80
- 52 Week Low
- TALO $9.44
- AMPH $36.56
- 52 Week High
- TALO $15.92
- AMPH $65.92
- Technical
- Relative Strength Index (RSI)
- TALO 47.36
- AMPH 59.40
- Support Level
- TALO $9.83
- AMPH $49.38
- Resistance Level
- TALO $10.66
- AMPH $51.84
- Average True Range (ATR)
- TALO 0.35
- AMPH 1.25
- MACD
- TALO 0.03
- AMPH 0.10
- Stochastic Oscillator
- TALO 46.24
- AMPH 78.90
About TALO Talos Energy Inc.
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.